Marquette Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96K Sell
80
-3
-4% -$3.06K 0.01% 133
2026
Q1
$76.3K Buy
83
+11
+15% +$11.2K 0.01% 89
2025
Q4
$77.4K Buy
72
+2
+3% +$1.91K 0.01% 88
2025
Q3
$53.4K Buy
+70
New +$52.1K 0.01% 99
2023
Q4
Sell
-27
Closed -$14.5K 248
2023
Q3
$14.5K Sell
27
-3
-10% -$1.55K ﹤0.01% 192
2023
Q2
$14.1K Buy
+30
New +$12.6K ﹤0.01% 206
2022
Q3
Sell
-4
Closed -$1K 323
2022
Q2
$1K Hold
4
﹤0.01% 263
2022
Q1
$1K Buy
+4
New +$1.03K ﹤0.01% 318

Other funds holding LLY

Marquette Asset Management's LLY Position: Q2 2026 in Review

Marquette Asset Management reduced its Eli Lilly (LLY) stake by 3.6% in Q2 2026, selling an estimated $3.06K and leaving 80 shares worth $96K. The position accounts for 0.01% of the portfolio, ranked #133.

Marquette Asset Management first reported a position in LLY in Q1 2022 and has held it in 8 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Marquette Asset Management held 80 shares of Eli Lilly worth $96K as of Q2 2026.
  • Marquette Asset Management sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.01% of Marquette Asset Management's portfolio in Q2 2026, its #133 holding.
  • Marquette Asset Management first reported a position in Eli Lilly in Q1 2022 and has held it in 8 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.